// App-Quantinova.ai

308 : Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for melanoma

Researchers

Presenter

  • Jeffrey Weber

Principal Investigators

  • Paolo Ascierto

  • Mark Middleton

  • Delphine Hennicken

  • Roberto Zoffoli

  • Anne Pieters

  • Adenike Amadi

  • Katrin Kupas

  • Srividya Kotapati

  • Andriy Moshyk

  • Dirk Schadendorf

Medical Centers

  • NYU Perlmutter Cancer Center, New York, NY

  • Istituto Nazionale Tumori Fondazione G. Pascale, Naples, Italy

  • OCDEM, University of Oxford, Oxford, UK

  • Bristol-Myers Squibb, Braine-lAlleud, Belgium

  • University Hospital of Essen, Essen, Germany

Locations

  • United States

  • Italy

  • United Kingdom

  • Belgium

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

Biomarkers

  • N/A

Drug/Treatment

  • Ipilimumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved